Edition:
India

AbbVie Inc (ABBV.N)

ABBV.N on New York Stock Exchange

68.32USD
17 Jul 2019
Change (% chg)

$-0.84 (-1.21%)
Prev Close
$69.16
Open
$69.35
Day's High
$69.83
Day's Low
$68.31
Volume
3,102,060
Avg. Vol
1,965,674
52-wk High
$100.23
52-wk Low
$65.06

About

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology,... (more)

Overall

Beta: 1.53
Market Cap(Mil.): $144,249.59
Shares Outstanding(Mil.): 1,594.09
Dividend: 0.64
Yield (%): 2.83

Financials

  ABBV.N Industry Sector
P/E (TTM): 22.10 29.88 32.67
EPS (TTM): 4.09 -- --
ROI: 11.74 14.90 14.49
ROE: 113.57 16.02 15.79

RPT-BUZZ-U.S. stocks weekly: Not half bad

(Repeats from Friday. Updates chart) ** S&P 500 snaps 3-week winning streak, slips 0.3% as all eyes are on G20 Summit. Though index finishes first half up 17.3%, the best start to a year since 1997 ** That said, charts suggest risk the SPX may have a bumpy ride ahead ** And while the DJI may still see another push , the Nasdaq's high hurdles may be too high ** This as lagging small caps may loom large ** Most sectors decline: Real estate and utilities fall most, while fin

01 Jul 2019

BUZZ-U.S. stocks weekly: Not half bad

** S&P 500 snaps 3-week winning streak, slips 0.3% as all eyes are on G20 Summit. Though index finishes first half up 17.3%, the best start to a year since 1997 ** That said, charts suggest risk the SPX may have a bumpy ride ahead ** And while the DJI may still see another push , the Nasdaq's high hurdles may be too high ** This as lagging small caps may loom large ** Most sectors decline: Real estate and utilities fall most, while financials and materials rise ** Heal

29 Jun 2019

U.S. dominates second quarter global M&A as mega deals roll on

NEW YORK/LONDON Mega deals set the pace for mergers and acquisitions (M&A) globally in the second quarter of 2019, as large U.S. companies defied trade row jitters and seized on strong equity and debt capital markets to agree on transformative combinations.

29 Jun 2019

UPDATE 1-U.S. dominates Q2 global M&A as mega deals roll on

NEW YORK/LONDON, June 28 Mega deals set the pace for mergers and acquisitions (M&A) globally in the second quarter of 2019, as large U.S. companies defied trade row jitters and seized on strong equity and debt capital markets to agree on transformative combinations.

29 Jun 2019

US syndicated lending disappoints with lowest 2Q tally in 7 years

NEW YORK, June 28 (LPC) - US syndicated lending turned in a lackluster performance in the second quarter, amounting to the lowest 2Q total in seven years and dashing expectations for a meaningful boost to first half issuance following an already lean start to 2019.

28 Jun 2019

U.S. dominates second-quarter global M&A as mega deals roll on

NEW YORK/LONDON Mega deals set the pace for mergers and acquisitions (M&A) globally in the second quarter of 2019, as large U.S. companies defied trade row jitters and seized on strong equity and debt capital markets to agree on transformative combinations.

28 Jun 2019

U.S. dominates Q2 global M&A as mega deals roll on

NEW YORK/LONDON, June 28 Mega deals set the pace for mergers and acquisitions (M&A) globally in the second quarter of 2019, as large U.S. companies defied trade row jitters and seized on strong equity and debt capital markets to agree on transformative combinations.

28 Jun 2019

CORRECTED-US loan market ready to feast on AbbVie's jumbo US$38bn bridge loan

NEW YORK, June 27 (LPC) - A US$38bn bridge loan backing US biopharmaceutical company AbbVie’s US$63bn bid for Botox-maker Allergan, and the additional bank business the merger will generate, is expected to be welcomed with open arms by a robust US loan market starved of new lending opportunities.

28 Jun 2019

PRESS DIGEST- New York Times business news - June 26

June 26 The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

26 Jun 2019

PRESS DIGEST- Wall Street Journal - June 26

June 26 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

26 Jun 2019

Earnings vs. Estimates